Vaccitech Limited logo

Vaccitech Limited

Vaccitech is a T cell immunotherapy company developing products to treat and prevent infectious disease and cancer

4

Funding Rounds

$215.6m

Money raised

Overview

Vaccitech is a T cell immunotherapy company developing products to treat and prevent infectious disease and cancer

Funding

Funding series

Funding Series Analysis

The company Vaccitech Limited has raised a total of $215.57m in funding over 4 rounds.

Key Insights:

  • Vaccitech Limited Series B round, March 2021: $168m
  • Vaccitech Limited Venture round, December 2018: $7.6m
  • Vaccitech Limited Series A round, January 2018: $27.58m
  • Vaccitech Limited Seed round, November 2016: $12.39m
Vaccitech Limited logo
Vaccitech Limited Series B round, March 2021 $168m
Vaccitech Limited logo
Vaccitech Limited Venture round, December 2018 $7.6m
Vaccitech Limited logo
Vaccitech Limited Series A round, January 2018 $27.58m
Vaccitech Limited logo
Vaccitech Limited Seed round, November 2016 $12.39m